1. 39.4 A DOUBLE-BLIND TRIAL OF VALACYCLOVIR TO IMPROVE COGNITION IN EARLY PHASE SCHIZOPHRENIA: RESULTS FROM THE VISTA STUDY. (1st April 2018) Authors: Breier, Alan; Dickerson, Faith; Buchanan, Robert; Marder, Stephen; Neuchterlein, Keith; D'Souza, Deepak; Francis, Michael; Radnovich, Alexander; Yolken, Robert; Preskorn, Sheldon; Macaluso, Matthew; Yang, Ziyi; Mehdyoun, Nicole; Kakar, Rishi; Dunn, Walter; Hoffmeyer, Debra; Maguire, Gerald Journal: Schizophrenia bulletin Issue: Volume 44(2018)Supplement 1 Page Start: S63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 39.4 EARLY AUDITORY PROCESSING IN SCHIZOPHRENIA: RELATIONSHIPS TO CLINICAL SYMPTOMS AND COGNITIVE REMEDIATION. (9th April 2019) Authors: Mccleery, Amanda; Wynn, Jonathan; Jahshan, Carol; Marder, Stephen; Roach, Brian; Mathalon, Daniel; Green, M F Journal: Schizophrenia bulletin Issue: Volume 45(2019)Supplement 2 Page Start: S152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bifactor Modeling of the Positive and Negative Syndrome Scale: Generalized Psychosis Spans Schizoaffective, Bipolar, and Schizophrenia Diagnoses. (6th February 2018) Authors: Anderson, Ariana E; Marder, Stephen; Reise, Steven P; Savitz, Adam; Salvadore, Giacomo; Fu, Dong Jing; Li, Qingqin; Turkoz, Ibrahim; Han, Carol; Bilder, Robert M Journal: Schizophrenia bulletin Issue: Volume 44:Number 6(2018:Nov.) Page Start: 1204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Issue 10074 (18th March 2017) Authors: Németh, György; Laszlovszky, István; Czobor, Pál; Szalai, Erzsébet; Szatmári, Balázs; Harsányi, Judit; Barabássy, Ágota; Debelle, Marc; Durgam, Suresh; Bitter, István; Marder, Stephen; Fleischhacker, W Wolfgang Journal: Lancet Issue: Volume 389:Issue 10074(2017) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Iclepertin (BI 425809) in Patients With Schizophrenia: CONNEX, A Phase III Randomized Controlled Trial Program. (April 2023) Authors: Wunderlich, Glen; Blahova, Zuzana; Hake, Sanjay; Ikezawa, Satoru; Marder, Stephen; Falkai, Peter; Krystal, John H. Journal: CNS spectrums Issue: Volume 28:Number 2(2023) Page Start: 229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The VA augmentation and switching treatments for improving depression outcomes (VAST-D) study: Rationale and design considerations. Issue 3 (30th October 2015) Authors: Mohamed, Somaia; Johnson, Gary R.; Vertrees, Julia E.; Guarino, Peter D.; Weingart, Kimberly; Young, Ilanit Tal; Yoon, Jean; Gleason, Theresa C.; Kirkwood, Katherine A.; Kilbourne, Amy M.; Gerrity, Martha; Marder, Stephen; Biswas, Kousick; Hicks, Paul; Davis, Lori L.; Chen, Peijun; Kelada, Alexan... Journal: Psychiatry research Issue: Volume 229:Issue 3(2015) Page Start: 760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗